OAC
PBYI icon

OMERS Administration Corp’s Puma Biotechnology PBYI Stock Holding History

OMERS Administration Corp’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,800
Closed -$89K – 1173
2024
Q1 		$89K Buy
+16,800
New +$90.5K ﹤0.01% 333
2016
Q2 		– Sell
-19,100
Closed -$561K – 637
2016
Q1 		$561K Buy
19,100
+15,000
+366% +$678K 0.01% 396
2015
Q4 		$321K Buy
+4,100
New +$322K 0.01% 411

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's PBYI Position: Q2 2024 in Review

OMERS Administration Corp sold out of Puma Biotechnology (PBYI) in Q2 2024, closing a stake of 16,800 shares — an estimated $89K sold.

OMERS Administration Corp first reported a position in PBYI in Q4 2015 and held it in 3 quarters. The position peaked at $561K in Q1 2016. 99 funds tracked by Wall St. Rank hold PBYI as of Q2 2024.

  • OMERS Administration Corp reported no remaining Puma Biotechnology position as of Q2 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 16,800 Puma Biotechnology shares in Q2 2024, an estimated $89K.
  • OMERS Administration Corp first reported a position in Puma Biotechnology in Q4 2015 and held it in 3 quarters.
  • OMERS Administration Corp's Puma Biotechnology position peaked at $561K in Q1 2016.
  • 99 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2024.

Based on OMERS Administration Corp's 13F filing for Q2 2024, filed 13 Aug 2024.